Clinical Use Cases Assessment of the Gabi System in Young Children With Underlying Medical Conditions (BRIDGE Study)

Inclusion Criteria

• •1. Infants and children \< 6 years old.
• •2. Subjects who present at least one of the following underlying medical conditions:
• •1. Subjects who underwent a congenital cardiac or cardiopulmonary surgery recently and could benefit from an additional post-surgery monitoring at home, per the investigator's opinion.
• •2. Subjects at risk awaiting surgery.
• •3. Subjects hospitalized following a severe respiratory condition within the past 2 weeks requiring invasive or non-invasive ventilation or oxygen therapy.
• •4. Subjects hospitalized following a severe cardiovascular condition within the past 2 weeks, including severe heart failure, tachycardia or bradycardia.
• •5. Subjects with chronic respiratory disease, such as asthma, developmental or cardiovascular conditions who could benefit from medical monitoring at home, per the investigator's opinion.
• •6. Subjects with chronic respiratory support at home.
• •7. Premature babies who required intensive neonatal care.
• •8. Subjects hospitalized following a Brief Resolved Unexpected Event (BRUE) within the past 2 weeks.
• •9. A clinical risk identified by the investigator which justifies the potential benefit of having a Gabi system used by the subject
• •3. Subject is (or is willing to be) followed up by an HCP of the investigation site during the duration of the study.
• •4. Signed informed consent form prior to performing any study specific procedure.
• •5. Willing and likely (based on the investigator's judgement) to comply with all study requirements.